Nasdaq · CIK 0000812796
SNGX SOLIGENIX, INC.
Insider trading from SEC Form 4. Last filing 24 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company
Signals
Open-market buys and sells at SOLIGENIX, INC., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 16 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Anthony Gregg Lapointe director | AGrant or award Stock Option (Right to Buy)derivative | +78,947 | $0.00 | $0 | 78,947 | 24 d ago |
| Sep 17, 2026 | Diane L. Parks director | AGrant or award Stock Option (Right to Buy)derivative | +78,947 | $0.00 | $0 | 78,947 | 24 d ago |
| Sep 17, 2026 | Robert J. Rubin director | AGrant or award Stock Option (Right to Buy)derivative | +78,947 | $0.00 | $0 | 78,947 | 24 d ago |
| Sep 17, 2026 | Jerome B Zeldis director | AGrant or award Stock Option (Right to Buy)derivative | +78,947 | $0.00 | $0 | 78,947 | 24 d ago |
| Jun 20, 2025 | Anthony Gregg Lapointe director | AGrant or award Stock Option (Right to Buy)derivative | +17,647 | $0.00 | $0 | 17,647 | Jun 20, 2025 |
| Jun 20, 2025 | Diane L. Parks director | AGrant or award Stock Option (Right to Buy)derivative | +17,647 | $0.00 | $0 | 17,647 | Jun 20, 2025 |
| Jun 20, 2025 | Robert J. Rubin director | AGrant or award Stock Option (Right to Buy)derivative | +17,647 | $0.00 | $0 | 17,647 | Jun 20, 2025 |
| Jun 20, 2025 | Jerome B Zeldis director | AGrant or award Stock Option (Right to Buy)derivative | +17,647 | $0.00 | $0 | 17,647 | Jun 20, 2025 |
| Dec 12, 2024 | Oreola Donini CSO | AGrant or award Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Dec 13, 2024 |
| Dec 12, 2024 | Jonathan L. Guarino CHIEF FINANCIAL OFFICER | AGrant or award Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Dec 13, 2024 |
| Dec 12, 2024 | Anthony Gregg Lapointe director | AGrant or award Stock Option (Right to Buy)derivative | +8,646 | $0.00 | $0 | 8,646 | Dec 13, 2024 |
| Dec 12, 2024 | Diane L. Parks director | AGrant or award Stock Option (Right to Buy)derivative | +8,646 | $0.00 | $0 | 8,646 | Dec 13, 2024 |
| Dec 12, 2024 | Robert J. Rubin director | AGrant or award Stock Option (Right to Buy)derivative | +8,646 | $0.00 | $0 | 8,646 | Dec 13, 2024 |
| Dec 12, 2024 | Christopher J Schaber CHAIRMAN, CEO AND PRESIDENT | AGrant or award Option (Right to Buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Dec 13, 2024 |
| Dec 12, 2024 | Jerome B Zeldis director | AGrant or award Stock Option (Right to Buy)derivative | +8,646 | $0.00 | $0 | 8,646 | Dec 13, 2024 |
| Dec 12, 2024 | Richard Straube SENIOR VICE PRESIDENT AND CMO | AGrant or award Option (Right to Buy)derivative | +12,000 | $0.00 | $0 | 12,000 | Dec 13, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Oreola DoniniCSO
- Jonathan L. GuarinoCHIEF FINANCIAL OFFICER
- Anthony Gregg Lapointedirector
- Diane L. Parksdirector
- Robert J. Rubindirector
- Christopher J SchaberCHAIRMAN, CEO AND PRESIDENT
- Richard StraubeSENIOR VICE PRESIDENT AND CMO
- Jerome B Zeldisdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.